Vimarsana
Biggest News Aggregation in the World

Dermavant Sciences Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dermavant Sciences Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dermavant Sciences Inc Today - Breaking & Trending Today

Atopic Dermatitis Market in North America: A $10,748.48 Million Market Poised for 14.8% Growth - Vimarsana News

Atopic Dermatitis Market in North America: A $10,748.48 Million Market Poised for 14.8% Growth

Atopic dermatitis, commonly known as eczema, is a chronic inflammatory skin condition affecting millions of individuals worldwide. In North America, this dermatological challenge presents a significant healthcare burden, prompting a deeper examination of the market dynamics surrounding its diagnosis, treatment, and...

Dermavant Sciences: Dermavant Announces Publication of ADORING 1 & ADORING 2 Pivotal Phase 3 Trials of VTAMA (tapinarof) cream, 1% for Adults and Children 2 Years of Age and Older with Atopic Dermatitis in JAAD - Vimarsana News

Dermavant Sciences: Dermavant Announces Publication of ADORING 1 & ADORING 2 Pivotal Phase 3 Trials of VTAMA (tapinarof) cream, 1% for Adults and Children 2 Years of Age and Older with Atopic Dermatitis in JAAD

- ADORING 1 and ADORING 2 met their primary efficacy endpoints and all secondary endpoints - - ADORING 1 and ADORING 2 data were included in the sNDA filing for VTAMA cream, 1% in atopic dermatitis

Dermavant Announces FDA Acceptance of Supplemental New Drug Application (sNDA) for VTAMA® (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older - Vimarsana News

Dermavant Announces FDA Acceptance of Supplemental New Drug Application (sNDA) for VTAMA® (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

LONG BEACH, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Apr 29, 2024--

Real World Data on Clinical Characteristics of Psoriasis Patients Treated with Tapinarof Cream - Vimarsana News

Real World Data on Clinical Characteristics of Psoriasis Patients Treated with Tapinarof Cream

This research provides an early analysis of plaque psoriasis patients within routine clinical practice settings and outside of a clinical trial setting.

Can We Do More for Topical Therapy in Pediatric Atopic Dermatitis? - Vimarsana News

Can We Do More for Topical Therapy in Pediatric Atopic Dermatitis?

It's key for clinicians to optimize therapy prior to systemic agents.